Molecular Biology Reports

, Volume 41, Issue 1, pp 317–324 | Cite as

Association between polymorphism in TRAF1/C5 gene and risk of rheumatoid arthritis: a meta-analysis

  • Xingang Zhang
  • Wei Li
  • Xinpeng Zhang
  • Xiaoli Zhang
  • Li Jiang
  • Yun Guo
  • Xiaofei Wang
Article

Abstract

Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disease. Single nucleotide polymorphisms of tumor necrosis factor-receptor associated factor 1/complement component 5 (TRAF1/C5) gene are suspected to be associated with the risk of RA. This meta-analysis was performed to study the relationship between the polymorphism rs10818488 in TRAF1/C5 gene with RA. We retrieved the relevant articles from PubMed, EMBASE and the China National Knowledge Infrastructure databases. Odd ratios were calculated to assess the association between TRAF1/C5 rs10818488 polymorphism and RA risk. Meta-analyses were performed on the total data set and separately for the major ethnic groups and RF and ACAP status. All analyses were performed using the Stata software. Eight articles were included in the present analysis. Meta-analysis showed a weak association between TRAF1/C5 rs10818488 polymorphism and RA in all subjects (OR = 1.13, 95 % CI = 1.01–1.27, P heterogeneity < 0.001). Stratified analyses indicated that the TRAF1/C5 rs10818488 A allele was significantly associated with RA in Caucasians (OR = 1.29, 95 %CI = 1.14–1.47, P heterogeneity = 0.026), Asians (OR = 0.92, 95 %CI = 0.86–0.99, P heterogeneity = 0.378) and Africans (OR = 1.56, 95 %CI = 1.23–1.98, P heterogeneity = 0.876), also significantly in positive ACPA and positive RF patients versus controls (ORs were 1.20 and 1.25, 95 %CIs were 1.08–1.33 and 1.14–1.37, P values for heterogeneity were 0.215 and 0.133, respectively). Genetic polymorphism rs10818488 in TRAF1/C5 gene might be associated with RA susceptibility.

Keywords

Rheumatiod arthritis Tumor necrosis factor-receptor associated factor 1/complement component 5 Single nucleotide polymorphism Meta-analysis 

Notes

Acknowledgments

The authors declare that they have no competing interests.

References

  1. 1.
    Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423(6937):356–361PubMedCrossRefGoogle Scholar
  2. 2.
    Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthr Res 4(Suppl 3):S265–S272CrossRefGoogle Scholar
  3. 3.
    Majithia V, Geraci SA (2007) Rheumatoid arthritis: diagnosis and management. Am J Med 120:936–939PubMedCrossRefGoogle Scholar
  4. 4.
    van der Helm-van Mil AH, Wesoly JZ, Huizinga TW (2005) Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol 17:299–304PubMedCrossRefGoogle Scholar
  5. 5.
    Bowes J, Barton A (2008) Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 47:399–402CrossRefGoogle Scholar
  6. 6.
    Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J, Alfredsson L, Begovich AB, Klareskog L, Huizinga TW, Toes RE (2007) A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 4(9):e278PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Chang M, Rowland CM, Garcia VE, Schrodi SJ, Catanese JJ, van der Helm-van Mil AH, Ardlie KG, Amos CI, Criswell LA, Kastner DL, Gregersen PK, Kurreeman FA, Toes RE, Huizinga TW, Seldin MF, Begovich AB (2008) A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet 4(6):e1000107PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253–259PubMedCrossRefGoogle Scholar
  9. 9.
    Tsitsikov EN, Laouini D, Dunn IF et al (2001) TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15:647–657PubMedCrossRefGoogle Scholar
  10. 10.
    Bradley JR, Pober JS (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20:6482–6491PubMedCrossRefGoogle Scholar
  11. 11.
    Zvaifler NJ (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265–336PubMedCrossRefGoogle Scholar
  12. 12.
    Fischetti F, Durigutto P, Macor P, Marzari R, Carretta R, Tedesco F (2007) Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. Arthr Rheumatol 56(4):1187–1197CrossRefGoogle Scholar
  13. 13.
    Palomino-Morales RJ, Rojas-Villarraga A, González CI, Ramírez G, Anaya JM, Martín J (2008) STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun 9(4):379–382PubMedCrossRefGoogle Scholar
  14. 14.
    Zervou MI, Sidiropoulos P, Petraki E, Vazgiourakis V, Krasoudaki E, Raptopoulou A, Kritikos H, Choustoulaki E, Boumpas DT, Goulielmos GN (2008) Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum Immunol 69(9):567–571PubMedCrossRefGoogle Scholar
  15. 15.
    Stark K, Rovenský J, Blazicková S, Grosse-Wilde H, Ferencik S, Hengstenberg C, Straub RH (2009) Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls. Arthr Res Ther 11(3):R70CrossRefGoogle Scholar
  16. 16.
    Nishimoto K, Kochi Y, Ikari K, Yamamoto K, Suzuki A, Shimane K, Nakamura Y, Yano K, Iikuni N, Tsukahara S, Kamatani N, Okamoto H, Kaneko H, Kawaguchi Y, Hara M, Toyama Y, Horiuchi T, Tao K, Yasutomo K, Hamada D, Yasui N, Inoue H, Itakura M, Yamanaka H, Momohara S (2010) Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheumatol Dis 69(2):368–373CrossRefGoogle Scholar
  17. 17.
    Zhu TT, Zhao DB (2011) Association of TRAF1 genes polymorphism with increased risk of rheumatoid arthritis in Han people. Chin J Rheumatol 15(1):22–25Google Scholar
  18. 18.
    Fakhfakh Karray E, Chalbi H, Ben Dhifallah I, Zakraoui L, Hamzaoui K (2012) Association study of TRAF1-C5 polymorphism with susceptibility to rheumatoid arthritis in Tunisian population. Joint Bone Spine 79(3):331–332PubMedCrossRefGoogle Scholar
  19. 19.
    Mohamed RH, Pasha HF, El-Shahawy EE (2012) Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population. Cell Immunol 273(1):67–72PubMedCrossRefGoogle Scholar
  20. 20.
    Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605PubMedCrossRefGoogle Scholar
  21. 21.
    Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Gibbons L, Plant D, Wellcome Trust Case Control Consortium, Wilson AG, Morgan A, Emery P, YEAR consortium, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Worthington J (2008) Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 17(15):2274–2279PubMedCrossRefGoogle Scholar
  22. 22.
    Kurreeman FA, Rocha D, Houwing-Duistermaat J, Vrijmoet S, Teixeira VH, Migliorini P, Balsa A, Westhovens R, Barrera P, Alves H, Vaz C, Fernandes M, Pascual-Salcedo D, Michou L, Bombardieri S, Radstake T, van Riel P, van de Putte L, Lopes-Vaz A, Prum B, Bardin T, Gut I, Cornelis F, Huizinga TW, Petit-Teixeira E, Toes RE, European Consortium on Rheumatoid Arthritis Families (2008) Replication of the tumor necrosis factor receptor-associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study. Arthr Rheumatol 58(9):2670–2674CrossRefGoogle Scholar
  23. 23.
    Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661–678CrossRefGoogle Scholar
  24. 24.
    Panoulas VF, Smith JP, Nightingale P, Kitas GD (2009) Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthr Rheumatol 60(1):39–46CrossRefGoogle Scholar
  25. 25.
    van Nies JA, Marques RB, Trompet S, de Jong Z, Kurreeman FA, Toes RE, Jukema JW, Huizinga TW, van der Helm-van Mil AH (2010) TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies. Arthr Res Ther 12(2):R38CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Xingang Zhang
    • 1
  • Wei Li
    • 2
  • Xinpeng Zhang
    • 3
  • Xiaoli Zhang
    • 1
  • Li Jiang
    • 1
  • Yun Guo
    • 1
  • Xiaofei Wang
    • 1
  1. 1.Department of RheumatologyShengjing Hospital of China Medical UniversityShenyangChina
  2. 2.Editorial Department of Chinese Pediatric Emergency MedicineShenyangChina
  3. 3.Department of NeurosurgeryThe Fourth People’s Hospital of Shenyang CityShenyangChina

Personalised recommendations